{"id":"https://openalex.org/W3083715971","doi":"https://doi.org/10.1158/1538-7445.am2020-ct185","title":"Abstract CT185: A phase II neoadjuvant trial of Interferon-gamma plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer","display_name":"Abstract CT185: A phase II neoadjuvant trial of Interferon-gamma plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083715971","doi":"https://doi.org/10.1158/1538-7445.am2020-ct185","mag":"3083715971"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-ct185","doi":"https://doi.org/10.1158/1538-7445.am2020-ct185","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-ct185","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059240684","display_name":"Hyo Sook Han","orcid":"https://orcid.org/0000-0002-0072-0257","observed_orcids":["https://orcid.org/0000-0002-0072-0257"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyo S. Han","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036804858","display_name":"Dawn Goodridge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dawn Goodridge","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046645773","display_name":"Avan J. Armaghani","orcid":"https://orcid.org/0000-0002-5426-3119","observed_orcids":["https://orcid.org/0000-0002-5426-3119"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Avan Armaghani","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100892722","display_name":"Ricardo Borges da Costa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Costa","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045174836","display_name":"Aixa Soyano Muller","orcid":"https://orcid.org/0000-0001-8421-4441","observed_orcids":["https://orcid.org/0000-0001-8421-4441"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aixa Soyano Muller","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026765782","display_name":"Loretta Loftus","orcid":"https://orcid.org/0009-0004-0996-7928","observed_orcids":["https://orcid.org/0009-0004-0996-7928"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Loretta Loftus","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Soliman","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004055647","display_name":"Brooke L. Fridley","orcid":"https://orcid.org/0000-0001-7739-7956","observed_orcids":["https://orcid.org/0000-0001-7739-7956"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brooke Fridley","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041394522","display_name":"Laila Khazai","orcid":"https://orcid.org/0000-0001-9388-6637","observed_orcids":["https://orcid.org/0000-0001-9388-6637"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laila Khazai","raw_affiliation_strings":["2MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022476952","display_name":"Aiana Cerezo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aiana Cerezo","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009532023","display_name":"Jesse Hevia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse Hevia","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058872511","display_name":"Marilin Rosa","orcid":"https://orcid.org/0000-0003-3247-6137","observed_orcids":["https://orcid.org/0000-0003-3247-6137"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilin Rosa","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014744153","display_name":"Hung T. Khong","orcid":"https://orcid.org/0000-0001-8365-957X","observed_orcids":["https://orcid.org/0000-0001-8365-957X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hung Khong","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051916408","display_name":"Brian J. Czerniecki","orcid":"https://orcid.org/0000-0003-4519-9570","observed_orcids":["https://orcid.org/0000-0003-4519-9570"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Czerniecki","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"CT185","last_page":"CT185"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.03550000116229057,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/weekly-paclitaxel","display_name":"weekly paclitaxel","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9100000262260437},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.6830000281333923},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.5839999914169312},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.40400001406669617},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.6079999804496765},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.597000002861023},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8817958831787109},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.8749710321426392},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.818252682685852},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7502208352088928},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6256612539291382},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6067954301834106},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5917866230010986},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5849180221557617},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5203444361686707},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4186161458492279},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.38487038016319275},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.318179726600647},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2965945601463318}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-ct185","doi":"https://doi.org/10.1158/1538-7445.am2020-ct185","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-ct185","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220900295","https://openalex.org/W2944233883","https://openalex.org/W4379285903","https://openalex.org/W3013417770","https://openalex.org/W2588133229","https://openalex.org/W4311582296","https://openalex.org/W3083832231","https://openalex.org/W2787103450","https://openalex.org/W2892046569","https://openalex.org/W3168724383"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"IFN-\u03b3,":[2],"a":[3,51,76,164,177,186],"cytokine":[4],"that":[5],"plays":[6],"diverse":[7],"roles":[8],"in":[9,20,27,37,57,65,130,157,419,442,500],"innate":[10],"and":[11,26,62,115,159,185,246,255,259,270,288,295,314,322,330,340,352,370,387,438,498,525],"adaptive":[12],"immunity,":[13],"has":[14],"been":[15],"shown":[16,31],"to":[17,149,209,216,222,364,409,427,429],"be":[18,205,217,447],"essential":[19],"anti-tumor":[21],"immune":[22],"response.":[23],"In":[24],"vitro":[25],"vivo":[28],"studies":[29],"have":[30],"the":[32,151,233,388,410,425,430,434,450,511,515],"synergistic":[33],"effect":[34],"of":[35,55,95,191,196,265,362,397,413,433,492,510,514],"IFN-\u03b3":[36,56,133,363],"combination":[38,58,131],"with":[39,43,59,81,132,182,375,395,415,502],"HER2-targeting":[40],"monoclonal":[41],"antibodies":[42],"or":[44,347],"without":[45],"taxane":[46],"chemotherapy.":[47],"We":[48],"previously":[49],"conducted":[50],"phase":[52,77,435,488],"I":[53,188],"trial":[54,437,491],"paclitaxel,":[60,368,496],"trastuzumab":[61,101,369,497],"pertuzumab":[63,116,371,499],"(IPTP)":[64],"metastatic":[66],"HER2-positive":[67],"breast":[68,158,505],"cancer":[69,304,506],"(HER2+BC)":[70],"based":[71,175],"on":[72,142,176],"which":[73,391,406],"we":[74,230],"initiated":[75],"II":[78,436,489],"neoadjuvant":[79,365,416,490],"study":[80,162,379],"this":[82],"combination.":[83],"Methods:":[84],"Early":[85],"stage":[86,180,252,432],"HER2+BC":[87],"patients":[88,170,203,241,249,280,501],"were":[89,171,242,257,333],"eligible.":[90],"Treatment":[91],"included":[92,319,349],"12":[93,307,384],"weeks":[94,105,120,385],"weekly":[96,140,495],"paclitaxel":[97],"80":[98],"mg/m2":[99],"IV,":[100],"IV":[102,117],"every":[103,118],"3":[104,119,271,344],"x":[106,121],"4":[107,122,355],"(8":[108],"mg/kg":[109],"loading":[110,125],"dose,":[111,126],"then":[112,127],"6":[113],"mg/m2)":[114],"(840":[123],"mg":[124],"420":[128],"mg)":[129],"50":[134],"mcg/m2":[135],"subcutaneous":[136],"injection":[137],"three":[138,240],"times":[139],"starting":[141],"day":[143],"1.":[144],"The":[145,193,276,284,324,360,399],"primary":[146],"objective":[147],"was":[148,281,292,357,372,392,404],"evaluate":[150],"pathologic":[152],"complete":[153],"response":[154],"rate":[155,190],"(pCR)":[156],"nodes.":[160],"This":[161,378,422],"had":[163,250,268,272],"planned":[165,234],"interim":[166,235],"analysis":[167,236],"after":[168],"23":[169,266],"evaluable":[172],"for":[173,207,219,278,286,401,518],"pCR":[174,213,277,285,396,400,412],"Simon's":[178],"two":[179],"design":[181],"90%":[183],"power":[184],"type":[187],"error":[189],"0.1.":[192],"final":[194],"proportion":[195],"hormone":[197],"receptor":[198],"(HR)":[199],"status":[200],"among":[201],"accrued":[202],"will":[204,446],"used":[206],"comparison":[208],"historical":[210],"control":[211],"because":[212],"is":[214],"expected":[215,411],"lower":[218],"HR+HER2+BC":[220,402],"compared":[221],"HR-HER2+BC":[223],"subtype":[224,403],"(25%":[225],"vs":[226],"50%":[227],"respectively).":[228],"Here":[229],"are":[231],"reporting":[232],"results.":[237],"Results:":[238],"Twenty":[239],"enrolled":[243],"between":[244],"1/2018":[245],"7/2019.":[247],"Most":[248],"clinical":[251],"II/III":[253],"(86%)":[254],"43%":[256],"clinically":[258],"pathologically":[260],"node":[261],"positive.":[262],"Nineteen":[263],"out":[264],"(82%)":[267],"HR+":[269],"invasive":[273],"lobular":[274],"carcinoma.":[275],"all":[279],"52%":[282],"(12/23).":[283],"HR+HER2+":[287,420],"HR-HER2+":[289],"BC":[290],"subgroup":[291],"57%":[293,405],"(11/19)":[294],"25%":[296,414],"(1/4)":[297],"respectively.":[298],"Further":[299],"evaluation":[300],"using":[301,367],"RCB":[302],"(residual":[303],"burden)":[305],"showed":[306],"pts":[308],"RCB-0,":[309],"5":[310,312],"RCB-I,":[311],"RCB-II,":[313],"1":[315,329],"RCB-III.":[316],"Two":[317],"SAE":[318],"pneumonitis/heart":[320],"failure":[321],"hematochezia.":[323],"most":[325],"frequently":[326],"observed":[327],"grade":[328,354],"2":[331],"AEs":[332],"fatigue":[334],"(69%),":[335],"diarrhea":[336,350],"(59%),":[337],"rash":[338],"(41%)":[339],"nausea":[341],"(41%).":[342],"Grade":[343],"toxicities":[345],"(4%":[346],"higher)":[348],"(n=3)":[351],"no":[353],"AE":[356],"noted.":[358],"Conclusion:":[359],"addition":[361],"chemotherapy":[366,417],"well":[373],"tolerated":[374],"manageable":[376],"toxicities.":[377],"evaluated":[380],"de-escalated":[381],"treatments":[382],"only":[383],"duration":[386],"anthracycline-free":[389],"regimen":[390,423],"highly":[393],"effective":[394],"52%.":[398],"compares":[407],"favorably":[408],"alone":[418],"patients.":[421],"met":[424],"criteria":[426],"proceed":[428],"second":[431],"appears":[439],"promising":[440],"especially":[441],"HR+HER2+BC.":[443],"Updated":[444],"results":[445],"presented":[448],"at":[449],"meeting":[451],"including":[452],"correlative":[453],"studies.":[454],"Citation":[455],"Format:":[456],"Hyo":[457],"S.":[458],"Han,":[459],"Dawn":[460],"Goodridge,":[461],"Avan":[462],"Armaghani,":[463],"Ricardo":[464],"Costa,":[465],"Aixa":[466],"Soyano":[467],"Muller,":[468],"Loretta":[469],"Loftus,":[470],"Hatem":[471],"Soliman,":[472],"Brooke":[473],"Fridley,":[474],"Laila":[475],"Khazai,":[476],"Aiana":[477],"Cerezo,":[478],"Jesse":[479],"Hevia,":[480],"Marilin":[481],"Rosa,":[482],"Hung":[483],"Khong,":[484],"Brian":[485],"Czerniecki.":[486],"A":[487],"Interferon-gamma":[493],"plus":[494],"HER-2":[503],"positive":[504],"[abstract].":[507],"In:":[508],"Proceedings":[509],"Annual":[512],"Meeting":[513],"American":[516],"Association":[517],"Cancer":[519,531],"Research":[520],"2020;":[521],"2020":[522],"Apr":[523],"27-28":[524],"Jun":[526],"22-24.":[527],"Philadelphia":[528],"(PA):":[529],"AACR;":[530],"Res":[532],"2020;80(16":[533],"Suppl):Abstract":[534],"nr":[535],"CT185.":[536]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-11T00:00:00"}